4-octyl itaconate改善了呼吸器引起的肺损伤
Xiudan Wang1, Weijing Kong2, Rui Yang2
1Department of Respiratory Medicine, The Third People's Hospital of Jinan, Jinan, Shandong, 250000, PR China.
4-octyl itaconate (OI) 通过减少炎症和氧化应激,保护免受呼吸器诱导的肺损伤 (VILI). 这种合成化合物在减轻机械通风引起的肺损伤方面表现有前途.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 呼吸机引起的肺损伤 (VILI) 是机械呼吸的严重并发症,其特点是免疫系统的调节失调和持续的炎症.
- 氧化应激和炎症酶激活,特别是NLRP3,是VILI病原发生的关键因素.
研究的目的:
- 调查合成伊塔科纳酸衍生物4-octyl伊塔科纳酸 (OI) 对VILI的保护作用.
- 阐明OI在缓解VILI的行动的潜在机制.
主要方法:
- 在接受机械通风 (MV) 之前,小鼠在腹腔内接受了OI治疗.
- 在周期性拉伸暴露之前,小鼠肺血管内皮细胞 (MLVEC) 经过不同度的OI预处理.
- 评估了氧化应激,炎症和NLRP3炎症酶激活的关键标志物.
主要成果:
- 胰岛素注射显著减弱了VILI,并减少了体内炎症反应.
- 抗氧化剂治疗增加了抗氧化酶的水平,例如超氧化解酶 (SOD),核因子E2相关因子2 (Nrf2) 和血红氧酶-1 (HO-1).
- OI降低了活性氧物种 (ROS) 和恶性甲酸 (MDA) 的水平,并抑制了NLRP3炎症酶途径的激活.
结论:
- 4-octyl itaconate显示出对VILI的显著保护作用.
- OI的治疗潜力在于其抑制氧化应激和抑制NLRP3炎症酶激活的能力,从而减轻肺损伤.
更多相关视频
08:00Intubation-mediated Intratracheal IMIT Instillation: A Noninvasive, Lung-specific Delivery System
Published on: November 17, 2014
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
相关概念视频
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation I: Indication and Settings
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
